Silence Therapeutics plc
SLNCF
$1.80
$0.2012.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.19M | 114.16M | 136.53M | 147.33M | 172.89M |
| Total Receivables | 22.18M | 20.04M | 16.84M | 26.91M | 22.19M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 13.12M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.26M | 14.36M | 16.42M | -- | 16.03M |
| Total Current Assets | 133.63M | 148.55M | 169.79M | 187.37M | 211.11M |
|
|
|||||
| Total Current Assets | 133.63M | 148.55M | 169.79M | 187.37M | 211.11M |
| Net Property, Plant & Equipment | 1.85M | 1.83M | 1.80M | 1.98M | 2.21M |
| Long-term Investments | 10.61M | 10.62M | 9.78M | 9.39M | 10.10M |
| Goodwill | 10.61M | 10.62M | 9.78M | 9.39M | 10.10M |
| Total Other Intangibles | 300.00K | 317.00K | 310.00K | 312.00K | 345.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 399.00K | 3.91M | 3.61M | 3.59M | 2.87M |
| Total Assets | 146.79M | 165.23M | 185.30M | 202.64M | 227.02M |
|
|
|||||
| Total Accounts Payable | 16.99M | 14.31M | 18.81M | 3.70M | 19.13M |
| Total Accrued Expenses | -- | -- | -- | 12.05M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 85.00K | -- | 60.00K | 117.00K | 186.30K |
| Total Finance Division Other Current Liabilities | 301.00K | 457.00K | 392.00K | 958.00K | 3.35M |
| Total Other Current Liabilities | 301.00K | 457.00K | 392.00K | 958.00K | 3.35M |
| Total Current Liabilities | 17.38M | 14.77M | 19.26M | 16.82M | 22.67M |
|
|
|||||
| Total Current Liabilities | 17.38M | 14.77M | 19.26M | 16.82M | 22.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 97.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 55.25M | 56.31M | 53.29M | 51.79M | 77.68M |
| Total Liabilities | 72.73M | 71.08M | 72.56M | 68.61M | 100.35M |
|
|
|||||
| Common Stock & APIC | 627.94M | 625.40M | 623.36M | 619.85M | 495.80M |
| Retained Earnings | -550.80M | -529.84M | -510.62M | -485.83M | -464.61M |
| Treasury Stock & Other | -3.07M | -1.40M | -- | -- | 95.50M |
| Total Common Equity | 74.06M | 94.16M | 112.74M | 134.02M | 126.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 74.06M | 94.16M | 112.74M | 134.02M | 126.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 74.06M | 94.16M | 112.74M | 134.02M | 126.68M |
|
|
|||||